Abstract

Summary Our knowledge of the therapeutic use of prostaglandins has increased dramatically in recent years. As clinical experience and familiarity with these agents grows, and is guided by properly conducted clinical trials, the true place of prostaglandins in clinical practice will become apparent. Unfortunately, much of the use of prostanoids today is based on uncontrolled studies and clinical impressions. Currently, the major roles for prostaglandins are in obstetric practice, in the treatment of ductus-dependent congenital heart disease, in the interim treatment of primary pulmonary hypertension, in acute post-CPB right ventricular afterload mismatch or right ventricular failure, and possibly in some forms of peripheral vascular disease.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.